4//SEC Filing
Poorvin David 4
Accession 0000908662-13-000146
CIK 0001177648other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:14 PM ET
Size
5.4 KB
Accession
0000908662-13-000146
Insider Transaction Report
Form 4
Poorvin David
Director
Transactions
- Award
Stock Option (right to buy)
2013-03-20+5,800→ 5,800 totalExercise: $14.00Exp: 2023-03-20→ Common Stock (5,800 underlying)
Footnotes (1)
- [F1]Such option will become exercisable monthly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equivalent is accumulated) over three years, beginning from the annual meeting of stockholders held on November 8, 2012.
Documents
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001305418
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:14 PM ET
- Size
- 5.4 KB